LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q1 2026 Earnings Call Transcript May 11, 2026
LENZ Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.32 EPS, expectations were $-1.1.
Operator: Good afternoon, ladies and gentlemen, and welcome to the LENZ Therapeutics’ First Quarter 2026 Financial Results Conference Call. [Operator Instructions] Following prepared remarks from management, we will conduct a question-and-answer session. And instructions will follow at that time. As a...
